Bagbudar, S. Et Al. 2023. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.. Medical oncology (Northwood, London, England) , vol.41, no.1 , 18.

Bagbudar, S., KARANLIK, H., Cabioglu, N., Bayram, A., Tükenmez, M., AYDINER, A., ... Yavuz, E.(2023). Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.. Medical oncology (Northwood, London, England) , vol.41, no.1, 18.

Bagbudar, Sidar Et Al. "Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.," Medical oncology (Northwood, London, England) , vol.41, no.1, 18, 2023

Bagbudar, Sidar Et Al. "Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.." Medical oncology (Northwood, London, England) , vol.41, no.1, pp.18, 2023

Bagbudar, S. Et Al. (2023) . "Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.." Medical oncology (Northwood, London, England) , vol.41, no.1, p.18.

@article{article, author={Sidar Bagbudar Et Al. }, title={Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.}, journal={Medical oncology (Northwood, London, England)}, year=2023, pages={18} }